Save
Email
Print
Share
RSSBrowse News Stories
151 to 160 of 304 stories
view headlines only
-
New Therapeutic Approach To Combat Lymphoma
March 12, 2009 — Using the human antibody, L19, which they developed themselves and specifically recognizes the blood vessels in tumor tissue, researchers have succeeded in eliminating lymphatic tumors in both mice ... > full story -
Iron Induces Death In Tumor Cells
March 11, 2009 — Tumor cells and healthy cells differ considerably in metabolism intensity. Scientists have now taken advantage of this difference; by releasing cellular iron, they were able to induce death ... > full story -
Study Maintenance Rituximab Is Useful For Advanced Indolent Lymphoma
March 10, 2009 — A new study has found for that maintenance therapy with the novel antibody, rituximab following cyclophosphamide, vincristine and prednisone therapy improves progression-free survival in patients ... > full story -
Wounds and Healing
Lymphoma
Gene Therapy
Personalized Medicine
Today's Healthcare
Diseases and Conditions
Rituximab Maintenance Therapy Improves Survival In Patients With Relapsed Follicular Lymphoma
February 10, 2009 — Patients with relapsed or refractory follicular lymphoma who continue on maintenance rituximab therapy after chemotherapy have better overall survival than patients who do not receive this treatment, ... > full story -
Deficiencies Common In Radiation Therapy Trial Reports For Hodgkin’s, Non-Hodgkin's Lymphoma
February 4, 2009 — Reporting of radiation therapy details in randomized controlled trials for Hodgkin's and non-Hodgkin's lymphoma is deficient due to a lack of reporting of key radiation therapy descriptors and ... > full story -
Enzyme That Mutates Antibodies Also Targets Cancer-Causing Oncogene
December 11, 2008 — The human immune system runs a risky business. It mutates its own DNA to diversify defenses against foreign invaders it has never before encountered. Unfortunately, these mutations sometimes miss the ... > full story -
Potential Breakthrough For T-Cell Lymphoma Patients With Drug That Mimics Folic Acid
December 9, 2008 — Preliminary results of a pivotal Phase 2 clinical trial of pralatrexate, a drug that partially works by mimicking folic acid, showed a complete or partial response in 27 percent of patients with ... > full story -
New Therapy Prevents Dangerous Side Effect For Lymphoma Patients, Study Suggests
December 9, 2008 — Patients respond well to a new three-drug combination for indolent B cell lymphoma that also spares them prolonged, potentially lethal, suppression of blood production in the bone marrow, researchers ... > full story -
Intense Chemotherapy Wards Off Recurrence In Half Of Mantle Cell Lymphoma Patients After Seven Years
December 9, 2008 — More than half of younger mantle cell lymphoma patients who received an intensive regimen of chemotherapy as front-line treatment remain in remission seven years later, researchers have ... > full story -
From Mother To Daughters: A Central Mystery In Cell Division Solved
December 9, 2008 — Researchers have identified a key step required for cell division in a study that could help improve therapies to treat cancer. Their work describing the mechanism of the contractile ring -- a ... > full story
Search ScienceDaily
Number of stories in archives: 137,310
more 
